Skip to main content
Top
Published in: Abdominal Radiology 3/2004

01-05-2004 | Pictorial essay

Hepatocellular carcinoma: Spectrum of contrast-enhanced gray-scale harmonic sonography findings

Authors: O. Catalano, R. Lobianco, B. Cusati, A. Siani

Published in: Abdominal Radiology | Issue 3/2004

Login to get access

Abstract

Sonography (US) is the most commonly used tool in the assessment of patients with chronic liver disease. Nevertheless, small nodules can be overlooked. Moreover, even if the lesion is readily recognizable, difficulty persists in differentiating hepatocellular carcinoma (HCC) from pre-tumoral, dysplastic stages of nodule evolution. In addition, US is the main tool in guiding percutaneous ablation therapies for HCC and in evaluating patients after treatment, but changes are not specific and difficulties persist in recognizing residual tumor during and after the ablation procedure. Contrast-enhanced, gray-scale, harmonic US offers new possibilities in the imaging of liver tumors. The real-time, low-mechanical index technique employed in our institution allows a true dynamic assessment of the tumor during the various phases of contrast medium circulation. This pictorial essay focuses on typical and atypical appearances of HCC when imaged with contrast-specific, real-time US. Findings useful for lesion detection, differential diagnosis, posttreatment assessment, and follow-up especially are illustrated. The potential role of contrast-enhanced US in various clinical settings is emphasized.
Literature
1.
go back to reference Lencioni, R, Cioni, D, Bartolozzi, C 2002Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasoundEur Radiol12151165PubMed Lencioni, R, Cioni, D, Bartolozzi, C 2002Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasoundEur Radiol12151165PubMed
2.
go back to reference Bartolozzi, C, Lencioni, R 2001Contrast-specific ultrasound imaging of focal liver lesions. Prologue to a promising future. Eur Radiol111314CrossRef Bartolozzi, C, Lencioni, R 2001Contrast-specific ultrasound imaging of focal liver lesions. Prologue to a promising future. Eur Radiol111314CrossRef
3.
go back to reference Burns, PN, Wilson, SR, Simpson, DH 2000Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrastInvest Radiol355871CrossRefPubMed Burns, PN, Wilson, SR, Simpson, DH 2000Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrastInvest Radiol355871CrossRefPubMed
4.
go back to reference Ding, H, Kudo, M, Maekawa, K, et al. 2001Detection of tumor parenchymal blood flow in hepatic tumors: value of second harmonic imaging with a galactose-based contrast agentHepatol Res21242251CrossRefPubMed Ding, H, Kudo, M, Maekawa, K,  et al. 2001Detection of tumor parenchymal blood flow in hepatic tumors: value of second harmonic imaging with a galactose-based contrast agentHepatol Res21242251CrossRefPubMed
5.
go back to reference Kim, TK, Choi, BI, Han, JK, et al. 2000Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic USRadiology216411417PubMed Kim, TK, Choi, BI, Han, JK,  et al. 2000Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic USRadiology216411417PubMed
6.
go back to reference Bauer, A, Solbiati, L, Wessman, N 2002Ultrasound imaging with SonoVue: low mechanical index real-time imagingAcad Radiol9282284CrossRef Bauer, A, Solbiati, L, Wessman, N 2002Ultrasound imaging with SonoVue: low mechanical index real-time imagingAcad Radiol9282284CrossRef
7.
go back to reference Lencioni, R, Cioni, D, Crocetti, L, et al. 2002Ultrasound imaging of focal liver lesions with second-generation contrast agentAcad Radiol9371374CrossRef Lencioni, R, Cioni, D, Crocetti, L,  et al. 2002Ultrasound imaging of focal liver lesions with second-generation contrast agentAcad Radiol9371374CrossRef
8.
go back to reference Bertolotto, M, Dalla Palma, L, Quaia, E, et al. 2000Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results.Eur Radiol1013691376CrossRefPubMed Bertolotto, M, Dalla Palma, L, Quaia, E,  et al. 2000Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results.Eur Radiol1013691376CrossRefPubMed
9.
go back to reference Numata, K, Tanaka, K, Kiba, T, et al. 2001Contrast-enhanced, wide-band harmonic gray scale imaging of hepatocellular carcinoma: correlation with helical computed tomographic imagesJ Ultrasound Med208998PubMed Numata, K, Tanaka, K, Kiba, T,  et al. 2001Contrast-enhanced, wide-band harmonic gray scale imaging of hepatocellular carcinoma: correlation with helical computed tomographic imagesJ Ultrasound Med208998PubMed
10.
go back to reference von Herbay, A, Vogt, C, Haussinger, D 2002Pulse inversion US in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions.J Ultrasound Med2111911200PubMed von Herbay, A, Vogt, C, Haussinger, D 2002Pulse inversion US in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions.J Ultrasound Med2111911200PubMed
11.
go back to reference Yamamoto, K, Shiraki, K, Deguchi, M, et al. 2002Diagnosis of hepatocellular carcinoma using digital subtraction imaging with contrast agent, Levovist: comparison with helical CT, digital subtraction angiography, and US angiographyOncol Rep9789792PubMed Yamamoto, K, Shiraki, K, Deguchi, M,  et al. 2002Diagnosis of hepatocellular carcinoma using digital subtraction imaging with contrast agent, Levovist: comparison with helical CT, digital subtraction angiography, and US angiographyOncol Rep9789792PubMed
12.
go back to reference Strobel, D, Raeker, S, Martus, P, et al. 2003Phase inversion harmonic imaging versus contrast-enhanced power Doppler US for the characterization of focal liver lesionsInt J Colorectal Dis1863672CrossRefPubMed Strobel, D, Raeker, S, Martus, P,  et al. 2003Phase inversion harmonic imaging versus contrast-enhanced power Doppler US for the characterization of focal liver lesionsInt J Colorectal Dis1863672CrossRefPubMed
13.
go back to reference Meuwly, JY, Schnyder, P, Gudinchet, F, et al. 2003Pulse-inversion harmonic imaging improves lesion conspicuity during US-guided biopsyJ Vasc Intervent Radiol14335341 Meuwly, JY, Schnyder, P, Gudinchet, F,  et al. 2003Pulse-inversion harmonic imaging improves lesion conspicuity during US-guided biopsyJ Vasc Intervent Radiol14335341
14.
go back to reference Skjoldbye, B, Pedersen, MH, Struckmann, J, et al. 2002Improved detection and biopsy of solid liver lesions using pulse-inversion ultrasound scanning and contrast agent infusionUltrasound Med Biol28439444CrossRefPubMed Skjoldbye, B, Pedersen, MH, Struckmann, J,  et al. 2002Improved detection and biopsy of solid liver lesions using pulse-inversion ultrasound scanning and contrast agent infusionUltrasound Med Biol28439444CrossRefPubMed
15.
go back to reference Numata, K, Isozaki, T, Ozawa, Y, et al. 2003Percutaneous ablation therapy guided by contrast-enhanced US for patients with hepatocellular carcinomaAJR180143149PubMed Numata, K, Isozaki, T, Ozawa, Y,  et al. 2003Percutaneous ablation therapy guided by contrast-enhanced US for patients with hepatocellular carcinomaAJR180143149PubMed
16.
go back to reference Ding, H, Kudo, M, Onda, H, et al. 2001Contrast-enhanced subtraction harmonic US for evaluating treatment response in patients with hepatocellular carcinomaAJR176661666PubMed Ding, H, Kudo, M, Onda, H,  et al. 2001Contrast-enhanced subtraction harmonic US for evaluating treatment response in patients with hepatocellular carcinomaAJR176661666PubMed
17.
go back to reference Ding, H, Kudo, M, Onda, H, et al. 2001Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CTRadiology221721730PubMed Ding, H, Kudo, M, Onda, H,  et al. 2001Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CTRadiology221721730PubMed
18.
go back to reference Wen, YL, Kudo, M, Zheng, RQ, et al. 2003Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic USAJR1815763PubMed Wen, YL, Kudo, M, Zheng, RQ,  et al. 2003Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic USAJR1815763PubMed
19.
go back to reference Esteban, JM, Gil, J 2002Therapeutic effect of chemoembolization therapy on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic imagingAcad Radiol9382383CrossRef Esteban, JM, Gil, J 2002Therapeutic effect of chemoembolization therapy on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic imagingAcad Radiol9382383CrossRef
20.
go back to reference Minami, Y, Kubo, M, Kawasaki, T, et al. 2003Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic USAJR180703708PubMed Minami, Y, Kubo, M, Kawasaki, T,  et al. 2003Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic USAJR180703708PubMed
21.
go back to reference Morimoto, M, Shirato, K, Sugimori, K, et al. 2003Contrast-enhanced harmonic gray-scale sonographic–histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinomaAJR1816569PubMed Morimoto, M, Shirato, K, Sugimori, K,  et al. 2003Contrast-enhanced harmonic gray-scale sonographic–histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinomaAJR1816569PubMed
22.
go back to reference Schneider, M, Arditi, M, Barrau, MB, et al. 1995BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubblesInvest Radiol30415417 Schneider, M, Arditi, M, Barrau, MB,  et al. 1995BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubblesInvest Radiol30415417
23.
go back to reference Catalano, O, Esposito, M, Nunziata, A, et al. 2000Multiphase helical CT findings after percutaneous ablation procedures for hepatocellular carcinomaAbdom Imaging25607614CrossRefPubMed Catalano, O, Esposito, M, Nunziata, A,  et al. 2000Multiphase helical CT findings after percutaneous ablation procedures for hepatocellular carcinomaAbdom Imaging25607614CrossRefPubMed
24.
go back to reference Solbiati, L, Tonolini, M, Cova, L, et al. 2003Guidance and control of percutaneous treatments.Solbiati, LMartegani, ALeen, E eds. Contrast-enhanced ultrasound of liver diseasesSpringer-Verlag ItaliaMilan103113 Solbiati, L, Tonolini, M, Cova, L,  et al. 2003Guidance and control of percutaneous treatments.Solbiati, LMartegani, ALeen, E eds. Contrast-enhanced ultrasound of liver diseasesSpringer-Verlag ItaliaMilan103113
Metadata
Title
Hepatocellular carcinoma: Spectrum of contrast-enhanced gray-scale harmonic sonography findings
Authors
O. Catalano
R. Lobianco
B. Cusati
A. Siani
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 3/2004
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-003-0107-x

Other articles of this Issue 3/2004

Abdominal Radiology 3/2004 Go to the issue

Book Reviews

Book reviews

Announcements

Announcements

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine